NSABP B-51/RTOG 1304: A Randomized Phase 3 Clinical Trial Evaluating Post-Mastectomy Chestwall and Regional Nodal XRT and Post Lumpectomy Regional Nodal XRT in Patients with Positive Axillary Nodes Before Neoadjuvant Chemotherapy who Convert to Pathologically Negative Axill

CTO - 8508
Cancer - Breast
  1. Females at least 18 years of age
  2. Life expectancy of at least 10 years, excluding diagnosis of breast cancer
  3. ECOG performance of 0 or 1; must have clinically T 1-3, N1 breast cancer at the time of diagnosis
  4. Must have pathologic confirmation of axillary nodal involvement at presentation
Tiffany Pearce